foxo4-dri senolytic 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4‐DRI improves the impaired ratio
Description
Three pilot studies, one investigator, roughly 30 subjects, and no randomized controlled trial
Some users report feeling intoxicated more quickly than before starting therapy
M.A.O.: Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writingoriginal draft, Writingreview and editing
Frequently Asked Questions Related Compounds Adipotide Mol
